GLP-1 Users Turn to Telehealth to Access Weight Loss Drugs

Justin Schrieber, CEO of telehealth company LifeMD, said that the main reason that Americans end up at virtual health care providers is to access GLP-1 weight loss medication, as well as other prescription medication. Schreiber said that there is still an untapped market for GLP-1 access and the next frontier of virtual access is for hormone replacement care. (Source: Bloomberg)